ELMD Stock Analysis: Buy, Sell, or Hold?

ELMD - Electromed, Inc.

ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
$27.97
-1.63 (-5.51%) β–Ό
5d: -30.58%
30d: -31.33%
90d: -23.64%
WAIT
LOW Confidence
Protect Your ELMD Gains
Analysis Updated: Aug 31, 2026 12:00 AM ET
Earnings: Aug 25, 2026 0d

Get Alerted When ELMD Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ELMD is down 30.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
See Forward Earnings Fair Value & Price Prediction β†’

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$63.57
Based on 12.8% avg growth
INTRINSIC VALUE TODAY
$39.47
29.1% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.7x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: ELMD is currently trading at $27.97, which is considered oversold relative to its 30-day fair value range of $35.21 to $43.31. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.9) compared to its historical average (23.7). Remarkably, the market is currently pricing in an annual earnings decline of 7.2% over the next few years. This pessimistic expectation contrasts with the company's recent 49.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, ELMD is in a strong uptrend. The price is currently testing key support at $27.81. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.5% recently.

Market Sentiment: ELMD scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (11th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $45.67 (+63.3%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $35.21 - $43.31
Company Quality Score 51/100 (HOLD)
Options IV Signal 11th percentile (COMPLACENCY WARNING)
Volume Confirmation HIGH
Confidence Score 61.5%

Protect Your Profits

Holding ELMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 11th percentile)
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-5.5%)
  • BULLISH: Trading 63.3% below Wall St target ($45.67)
  • WARNING: Composite score 51/100 in the bottom quintile β€” this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $35.21 - $43.31
Current vs Trading Range OVERSOLD
Expected Move (7 Days) Β±$1.69 (6.1%)

Support & Resistance Levels

Support Level $27.81
Resistance Level $42.00
Current Trend Strong Uptrend
Technical data as of Aug 31, 2026

Fundamental Context

Forward P/E (Next Year Est.) 18.90
Wall Street Target $45.67 (+63.3%)
Revenue Growth (YoY) 11.6%
Earnings Growth (YoY) 49.0%
Profit Margin 15.3%
Valuation Discount vs History -7.2% cheaper
PE vs Historical 18.9 vs 23.7 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -7.2% (market-implied from PE analysis)
1-Year Target $25.96 (-7%)
2-Year Target $24.09 (-14%)
3-Year Target $22.35 (-20%)
3-Yr Target (if PE normalizes) (PE: 19β†’24) $28.03 (+0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 20.1, Growth: 21.6%) $53.54 (+91%)
Base: (SPY PE: 18.9, Growth: 21.6%) $50.34 (+80%)
Bear: (PE: 16.1, Growth: 21.6%) $42.79 (+53%)
πŸ“ˆ Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (23x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 23.12 | Current EPS (TTM): $1.28
Bull Case $37.65 (+35%)
Analyst growth 15.6%, PE expands to 25.4
Base Case $34.23 (+22%)
Market implied 15.6%, PE stable at 23.1
Bear Case $20.13 (-28%)
Severe decline -20.0%, PE contracts to 19.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
πŸ’‘ Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.9 to 23.7
Stabilization Target: $35.08 (+25.4%)
PE Expansion Potential: +25.4%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 31, 2026 7:44 PM ET
Data refreshes hourly during market hours. Next update: 8:44 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ELMD.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BSX
Boston Scientific Corp
STRONG BUY
34 analysts
$63 50 HOLD
SYK
Stryker Corporation
BUY
32 analysts
$383 61 BUY
PODD
Insulet Corporation
STRONG BUY
24 analysts
$172 60 HOLD
DXCM
DexCom Inc
STRONG BUY
27 analysts
$94 43 HOLD
MDT
Medtronic PLC
BUY
32 analysts
$98 46 HOLD

Advanced ELMD Option Strategies

Professional options setups generated by AI based on today's ELMD price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ELMD

ELMD Technical Chart ELMD Price Prediction ELMD Earnings Date ELMD Investment Advisor ELMD Fair Price Analyzer ELMD Options Advisor ELMD Options Chain ELMD Options Analysis ELMD Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals